Description
| Product Name | CAT.No | Size |
| AFP | AFPC0040 | 40T |
Product Description
The Biorex Diagnostics AFP Rapid Test Device is a rapid, chromatographic immunoassay designed for the qualitative detection of Alpha-Fetoprotein in human serum or plasma. It enables fast and reliable screening to support clinical assessment in oncology, hepatology, and maternal-foetal care settings. By delivering qualitative results within minutes and requiring no specialised instruments, the device offers an efficient solution for point-of-care and laboratory workflows.
Clinical Application and Background
Alpha-Fetoprotein is a tumour marker associated with hepatocellular carcinoma and certain germ cell tumours. Elevated levels may indicate liver malignancy or ongoing disease activity, making AFP screening useful in high-risk patient monitoring and treatment evaluation. In maternal health, AFP measurement contributes to prenatal screening for foetal neural tube defects and can assist clinicians in identifying complications requiring additional diagnostic investigation.
Key Features
• Rapid chromatographic immunoassay – provides clear, qualitative results within minutes
• High sensitivity and specificity – reliably identifies abnormal biomarker levels
• Compatible with serum or plasma – minimal sample volume required
• Instrument-free testing – suitable for both laboratory and point-of-care settings
• Ready-to-use format – simplified workflow, minimal preparation, reduced handling errors
• Versatile clinical use – supports oncology, hepatology, and prenatal care applications
Benefits
Routine use of the Biorex Diagnostics AFP Rapid Test Device assists clinicians in evaluating liver cancer risk, monitoring therapy response, and identifying potential disease recurrence in at-risk populations. Its rapid performance and reliable visual interpretation enhance clinical decision-making, enable earlier interventions, and improve patient management in oncology and hepatology settings.
In maternal-foetal care, qualitative AFP screening supports prenatal evaluation and may prompt further diagnostic testing when abnormal results are observed. The test’s simplicity and compatibility with common sample types streamline workflow, reduce turnaround times, and make it suitable for diverse healthcare environments, including hospitals, specialist clinics, and community diagnostic centres.
Overall, the Biorex Diagnostics AFP Rapid Test Device provides a convenient, clinically valuable, and cost-effective tool for qualitative Alpha-Fetoprotein detection, supporting improved patient outcomes across multiple medical disciplines.
Contact Us for more information.